Evaxion is pioneering the field of immunoinformatics, working hard to bring novel, highly effective vaccines and antibodies to patients. By converting complex immunological data into computational algorithms, Evaxion is capable of programming the immune system to fight off a variety of diseases from cancers to hard-to-treat anti-microbial resistant infections.

Biotechnology

Evaxion Biotech

Christian Kanstrup

Anne Sofie Wiemann

Anders Helmer

Mark Schefferling

Sophie Schussek

Stine Friis

Christian Garde

Casper Veje Anker

Jesper Nyegaard Nissen

Rikke Søborg Sevel

Birgitte Rønø

Andreas Holm Mattsson

The leadership team at Evaxion Biotech has a history of experience in the diabetes complication research field from Novo Nordisk, as well as post-doctoral work at Lund University and the University of Copenhagen. In addition, members of the team have served on the board of directors for Aquaporin US Inc., Aquaporin Asia Pte. Ltd., and Golgi ApS. The team's Vice Chairman of the Board also has a background in business administration and audit from the Copenhagen Business School.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Evaxion Biotech

Board of Directors

CEO and Executive Team